A99T (p.Ala99Thr) variant of NLGN3 (Neuroligin-3)

A99T (p.Ala99Thr) in NLGN3 (Neuroligin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.65 / 1. The record also includes population frequency data and structural context.

A99T (p.Ala99Thr) variant details